I added AFFY yesterday when it broke $11. I am hoping that it can run a bit more ahead of the FDA decision on March 28th. It’s risky because it has already appreciated considerably since the Ad. Comm. voted overwhelmingly in its favour but the February’s range bound trading leads me to think that a break of $11 may be significant.